ID

27501

Descripción

Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?; ODM derived from: https://clinicaltrials.gov/show/NCT00430170

Link

https://clinicaltrials.gov/show/NCT00430170

Palabras clave

  1. 19/11/17 19/11/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

19 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Cardiovascular Disease NCT00430170

Eligibility Cardiovascular Disease NCT00430170

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male
Descripción

Gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
age between 18-50yr.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
cardiovascular disease
Descripción

Cardiovascular Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
hypertension (systole > 140 mmhg, diastole > 90 mmhg)
Descripción

Hypertensive disease | Systolic Pressure | Diastolic blood pressure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
hypercholesterolemia (random total cholesterol > 6.5 mmol/l)
Descripción

Hypercholesterolemia | Serum total cholesterol measurement Random

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020443
UMLS CUI [2,1]
C1445957
UMLS CUI [2,2]
C0439605
diabetes mellitus (fasting glucose > 7.0 mmol/l or random glucose > 11.0 mmol/l)
Descripción

Diabetes Mellitus | Serum fasting glucose measurement | Serum random glucose measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011849
UMLS CUI [2]
C0583334
UMLS CUI [3]
C0583333
asthma (recurrent episodes of dyspnea and wheezing, or usage of prescribed inhalation medication: i.e. corticosteroids or b2-agonists)
Descripción

Asthma | Dyspnea Recurrent episode | Wheezing Recurrent episode | Inhalation Drug Administration prescribed | Adrenal Cortex Hormones | beta2-Adrenergic Agonist

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2,1]
C0013404
UMLS CUI [2,2]
C0443287
UMLS CUI [3,1]
C0043144
UMLS CUI [3,2]
C0443287
UMLS CUI [4,1]
C0001559
UMLS CUI [4,2]
C0278329
UMLS CUI [5]
C0001617
UMLS CUI [6]
C2917450
participation in any clinical trial during the last 60 days prior to this study.
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
administration of two doses of annexin a5 (0,1mg; 450mbq) during the last 5 years prior to this study.
Descripción

Annexin A5 Dose Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0059249
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C1265611

Similar models

Eligibility Cardiovascular Disease NCT00430170

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender
Item
male
boolean
C0079399 (UMLS CUI [1])
Age
Item
age between 18-50yr.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cardiovascular Disease
Item
cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Hypertensive disease | Systolic Pressure | Diastolic blood pressure
Item
hypertension (systole > 140 mmhg, diastole > 90 mmhg)
boolean
C0020538 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Hypercholesterolemia | Serum total cholesterol measurement Random
Item
hypercholesterolemia (random total cholesterol > 6.5 mmol/l)
boolean
C0020443 (UMLS CUI [1])
C1445957 (UMLS CUI [2,1])
C0439605 (UMLS CUI [2,2])
Diabetes Mellitus | Serum fasting glucose measurement | Serum random glucose measurement
Item
diabetes mellitus (fasting glucose > 7.0 mmol/l or random glucose > 11.0 mmol/l)
boolean
C0011849 (UMLS CUI [1])
C0583334 (UMLS CUI [2])
C0583333 (UMLS CUI [3])
Asthma | Dyspnea Recurrent episode | Wheezing Recurrent episode | Inhalation Drug Administration prescribed | Adrenal Cortex Hormones | beta2-Adrenergic Agonist
Item
asthma (recurrent episodes of dyspnea and wheezing, or usage of prescribed inhalation medication: i.e. corticosteroids or b2-agonists)
boolean
C0004096 (UMLS CUI [1])
C0013404 (UMLS CUI [2,1])
C0443287 (UMLS CUI [2,2])
C0043144 (UMLS CUI [3,1])
C0443287 (UMLS CUI [3,2])
C0001559 (UMLS CUI [4,1])
C0278329 (UMLS CUI [4,2])
C0001617 (UMLS CUI [5])
C2917450 (UMLS CUI [6])
Study Subject Participation Status
Item
participation in any clinical trial during the last 60 days prior to this study.
boolean
C2348568 (UMLS CUI [1])
Annexin A5 Dose Quantity
Item
administration of two doses of annexin a5 (0,1mg; 450mbq) during the last 5 years prior to this study.
boolean
C0059249 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial